Cargando…

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy

ER maleate [10-(3-Aminopropyl)-3, 4-dimethyl-9(10H)-acridinone maleate] identified in a kinome screen was investigated as a novel anticancer agent for oral squamous cell carcinoma (OSCC). Our aim was to demonstrate its anticancer effects, identify putative molecular targets and determine their clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Guodong, Somasundaram, Raj Thani, Jessa, Fatima, Srivastava, Gunjan, MacMillan, Christina, Witterick, Ian, Walfish, Paul G., Ralhan, Ranju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941378/ https://www.ncbi.nlm.nih.gov/pubmed/26934445 http://dx.doi.org/10.18632/oncotarget.7751

Ejemplares similares

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy
por: Srivastava, Gunjan, et al.
Publicado: (2015)

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
por: Somasundaram, Raj Thani, et al.
Publicado: (2016)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions
por: Hsieh, Anne M.-Y., et al.
Publicado: (2018)

Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012)

Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
por: Srivastava, Gunjan, et al.
Publicado: (2014)

Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
por: Assi, Jasmeet, et al.
Publicado: (2013)

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model
por: Hasan, Raghibul, et al.
Publicado: (2022)

Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression
por: Kaur, Jatinder, et al.
Publicado: (2013)

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
por: Chauhan, S S, et al.
Publicado: (2015)

Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens
por: Fu, Guodong, et al.
Publicado: (2021)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma
por: He, Helen C.-H., et al.
Publicado: (2012)

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules
por: Fu, Guodong, et al.
Publicado: (2023)

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
por: Kumar, Manish, et al.
Publicado: (2015)

Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
por: Bansal, Ranju, et al.
Publicado: (2021)

Trimipraminium maleate
por: Jasinski, Jerry P., et al.
Publicado: (2010)

Estimation of Tegaserod Maleate by Differential Pulse Polarography
por: Rajput, S. J., et al.
Publicado: (2009)

Clinical significance of Phosphatidyl Inositol Synthase overexpression in oral cancer
por: Kaur, Jatinder, et al.
Publicado: (2010)

Creatininium hydrogen maleate
por: Jahubar Ali, A., et al.
Publicado: (2011)

Flunarizinium hydrogen maleate
por: Kavitha, Channappa N., et al.
Publicado: (2013)

Maleate salts of bedaquiline
por: Zeller, Matthias, et al.
Publicado: (2021)

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis
por: Hasan, Raghibul, et al.
Publicado: (2014)

Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients
por: Hasan, Md. Raghibul, et al.
Publicado: (2013)

Crystal structure of levomepromazine maleate
por: Gál, Gyula Tamás, et al.
Publicado: (2016)

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
por: Matta, Ajay, et al.
Publicado: (2009)

ZnO Nanoparticles: A Promising Anticancer Agent
por: Bisht, Gunjan, et al.
Publicado: (2016)

Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy
por: Li, Xiao, et al.
Publicado: (2022)

Over-expression of 14-3-3zeta is an early event in oral cancer
por: Matta, Ajay, et al.
Publicado: (2007)

2-Methylimidazolium hydrogen maleate
por: Liu, Zhi-Xiong
Publicado: (2009)

2-Carboxypyridinium maleate
por: Pandi, P., et al.
Publicado: (2012)

Anaphylaxis to Chlorpheniramine Maleate and Literature Review
por: Choi, Yong Won, et al.
Publicado: (2019)

Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2021)

Alcohols as alkylating agents in heteroarene C–H functionalization
por: Jin, Jian, et al.
Publicado: (2015)

14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells
por: Macha, Muzafar A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_349a1ocre4c2of0l6aaigq68ht